Mutated IKZF1 Is an Independent Marker of Adverse Risk in Acute Myeloid Leukemia

In a multicenter cohort of 1606 newly diagnosed and intensively treated adult AML patients, researchers found IKZF1 alterations in 45 cases with a mutational hotspot at N159S.